Xeris Pharmaceuticals | XERS - Revenu Net





Revenu Net Changement Date
Celltrion KRW 8.82B 64.74M 2026-03
Cspc Pharmaceutical CNY 370.72M 592.81M 2025-12
Deva Holding AS TRY 583.98M 319.1M 2023-09
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 7.51B 1.68B 2026-03
Eli Lilly USD 7.4B 760M 2026-03
Kangmei Pharma CNY -16.56M 12.74M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
Malin Corporation EUR -1.1M 2.2M 2023-12
Medical Developments International AUD -226K 121K 2025-12
Nektar Therapeutics USD -36.08M 978K 2025-12
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Organigram Holdings CAD -921K 20.89M 2026-03
Ovoca Bio EUR -765K 4.89M 2025-06
Pacira USD 2.92M 1.28M 2026-03
Perrigo USD -398.6M 1.02B 2026-03
Pharma Mar EUR 1.53M 58.13M 2026-03
Qiagen NV USD 68.04M 39.79M 2026-03
Sartorius EUR 65.9M 9.7M 2026-06
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Supernus Pharmaceuticals USD -2.29M 1.81M 2026-03
Tilray USD -44.93M 44.61M 2025-09
Zealand Pharma A/S -379.12M 25.12M 2025-12
Zz Pientze Pharmaceu CNY 743.48M 56.45M 2026-03